Bin Li
Impact in
- Cancer Research top 0.2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 0.5%
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Circular RNAs in diseases
- RNA Research and Splicing
Papers in
-
- RNA modifications and cancer 45
- Epigenetics and DNA Methylation 36
- Circular RNAs in diseases 23
- RNA Research and Splicing 21
- Cancer-related gene regulation 20
- Cancer Research 103
- Cancer-related molecular mechanisms research 53
- MicroRNA in disease regulation 40
- Co-authors
- Wen Xu (13 shared papers)Qing‐Yu He (34 shared papers)Yan He (8 shared papers)Jing Yang (6 shared papers)Stanley Fields (3 shared papers)Miao Sun (1 shared paper)Kui Sheng Chen (1 shared paper)Yuan‐Han Yang (4 shared papers)
- Journals
- Oncotarget (13 papers)PLoS ONE (8 papers)Oncology Reports (7 papers)Journal of Clinical Oncology (6 papers)Frontiers in Oncology (6 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Bin Li
385 papers receiving 10.8k citations
Bin Li's Hit Papers
Peers
Comparison fields: 5 of 168
- Cancer Research 2.7k
- Molecular Biology 6.0k
- Oncology 1.8k
- Pulmonary and Respiratory Medicine 1.3k
- Immunology 809
Countries citing papers authored by Bin Li
This map shows the geographic impact of Bin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Li more than expected).
Fields of papers citing papers by Bin Li
This network shows the impact of papers produced by Bin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Li. The network helps show where Bin Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Bin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 400 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Targeting PI3K/Akt signal transduction for cancer therapy Hit paper breakdown → | 2021 | 1160 |
| 2 | Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition Hit paper breakdown → | 2016 | 478 |
| 3 | Advances in targeted therapy for esophageal cancer Hit paper breakdown → | 2020 | 338 |
| 4 | Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment Hit paper breakdown → | 2021 | 249 |
| 5 | 1993 | 198 | |
| 6 | New insights into the interplay between long non‐coding RNAs and RNA‐binding proteins in cancer Hit paper breakdown → | 2022 | 197 |
| 7 | 2014 | 190 | |
| 8 | 2017 | 184 | |
| 9 | 1998 | 171 | |
| 10 | Use of the two-hybrid system to identify the domain of p53 involved in oligomerization. | 1993 | 159 |
| 11 | 2012 | 117 | |
| 12 | Lysine 2-hydroxyisobutyrylation of NAT10 promotes cancer metastasis in an ac4C-dependent manner Hit paper breakdown → | 2023 | 111 |
| 13 | 2021 | 111 | |
| 14 | Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas. | 2003 | 109 |
| 15 | 2015 | 105 | |
| 16 | 1996 | 100 | |
| 17 | 2009 | 100 | |
| 18 | 2015 | 98 | |
| 19 | 2017 | 97 | |
| 20 | 2013 | 96 |
About Bin Li
Bin Li is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Surgery, having authored 400 papers that have together received 10.9k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (53 papers), RNA modifications and cancer (45 papers), MicroRNA in disease regulation (40 papers), Epigenetics and DNA Methylation (36 papers), Circular RNAs in diseases (23 papers), Lung Cancer Treatments and Mutations (22 papers), RNA Research and Splicing (21 papers) and Cancer-related gene regulation (20 papers). The work is most often cited by research in Cancer Research (2.7k citations), Molecular Biology (6.0k citations), Oncology (1.8k citations), Pulmonary and Respiratory Medicine (1.3k citations) and Immunology (809 citations). Bin Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Wen Xu, Qing‐Yu He, Yan He, Jing Yang, Stanley Fields, Miao Sun, Kui Sheng Chen, Yuan‐Han Yang, Can‐Can Zheng and Hang Fai Kwok. Their work appears in journals such as Oncotarget, PLoS ONE, Oncology Reports, Journal of Clinical Oncology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.